FMDT insider filings
4D Molecular Therapeutics, Inc. — 11 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-10-03. Screen FMDT transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for FMDT between 2026-07-10 and 2026-10-08. The table below lists the most recent filings on record.
Recent insider filings — 4D Molecular Therapeutics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2023-10-03 | 4 | Mehra Uneek — See Remarks | Grant/award (A): 229,634 (derivative) @ $0 | EDGAR |
| 2023-06-12 | 4 | Bizily Scott — Chief Legal and HR Officer | Option exercise (M): 3,750 @ $8.04 · Sale (S): 3,750 @ $20.85 · Option exercise (M): 3,750 (derivative) @ $0 | EDGAR |
| 2023-06-06 | 4 | Bizily Scott — Chief Legal and HR Officer | Option exercise (M): 1,875 @ $6.49 · Sale (S): 2,247 @ $18.31 · Option exercise (M): 1,875 (derivative) @ $0 | EDGAR |
| 2023-05-25 | 4 | Miller-Rich Nancy — Director | Grant/award (A): 22,500 (derivative) @ $0 | EDGAR |
| 2023-05-25 | 4 | GRAY SUSANNAH — Director | Grant/award (A): 22,500 (derivative) @ $0 | EDGAR |
| 2023-05-25 | 4 | Kasahara Noriyuki — Director | Grant/award (A): 22,500 (derivative) @ $0 | EDGAR |
| 2023-05-25 | 4 | THEUER CHARLES — Director | Grant/award (A): 22,500 (derivative) @ $0 | EDGAR |
| 2023-05-25 | 4 | Tomasello Shawn — Director | Grant/award (A): 22,500 (derivative) @ $0 | EDGAR |
| 2023-05-25 | 4 | Chacko Jacob — Director | Grant/award (A): 22,500 (derivative) @ $0 | EDGAR |
| 2023-05-25 | 4 | MILLIGAN JOHN F — Director | Grant/award (A): 33,750 (derivative) @ $0 | EDGAR |
| 2023-05-16 | 4 | Moretti August J — Chief Financial Officer | Option exercise (M): 3,000 @ $9.41 · Option exercise (M): 3,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — 4D Molecular Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-28 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-08-13 | 8-K | 2.02 — Results of Operations and Financial Condition | EDGAR |
| 2026-07-20 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-06-29 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant | EDGAR |
| 2026-06-22 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-30 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-03-18 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-26 | 8-K | 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-07 | 8-K | 2.02 — Results of Operations and Financial Condition 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=FMDT returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →